Previous Close | 1.27 |
1-Year Change | 23.3% |
6-Months Change | -29.05% |
3-Months Change | -20.13% |
Moving Avg (50d) | 1.6656 |
Moving Avg (200d) | 1.9095 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 311.1M |
Beta (3-Years) | 1.65 |
Revenue Growth (ttm) | -49540.8% |
Net Profit Margin (ttm) | 255.43% |
Return On Assets (ttm) | -57.1% |
EPS (ttm) | -0.76 |
PE Ratio (ttm) | -1.67 |
Dividend Yield | % |
Asset Description: | Lexicon Pharmaceuticals, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2024-10-22 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
1.295 | 1.333 | 1.359 | 1.397 | 1.46 | 1.524 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.